Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms

Robert Slinger1, Francis Chan, Wendy Ferris

  • 1Department of Pediatrics, Ottawa, Ontario, Canada K1H 8L1. slinger@cheo.on.ca

Insights

Haemophilus influenzae biofilms are more resistant to antibiotics than planktonic cultures. Novel antibiotic combinations, particularly those with rifampin and ciprofloxacin, show promise for treating otitis media with effusion (OME).

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Otolaryngology

Background:

  • Haemophilus influenzae is a common cause of otitis media with effusion (OME).
  • OME often shows poor response to standard antibiotic treatments.
  • In vitro and animal models suggest H. influenzae biofilms contribute to OME's antibiotic resistance.

Purpose of the Study:

  • To compare antibiotic susceptibility between H. influenzae biofilm and planktonic cultures.
  • To identify antibiotics and combinations effective against H. influenzae biofilms.
  • To inform potential new therapeutic strategies for OME.

Main Methods:

  • H. influenzae isolates were cultured as biofilms on polystyrene pins.
  • Minimum inhibitory concentrations (MICs) were determined for 8 antibiotics against biofilm and planktonic cultures.
  • Combination testing was performed using 66 different antibiotic groupings (1-3 drugs).

Main Results:

  • H. influenzae biofilm cultures exhibited significantly higher antibiotic resistance compared to planktonic cultures.
  • Antibiotic combinations including rifampin and ciprofloxacin demonstrated the greatest efficacy against biofilms.
  • Biofilm susceptibility testing revealed differential antibiotic effectiveness not observed in standard testing.

Conclusions:

  • Antibiotic resistance in H. influenzae biofilms is a key factor in OME treatment failure.
  • Rifampin and ciprofloxacin combinations represent a promising novel therapeutic approach for OME.
  • In vitro biofilm susceptibility testing is crucial for guiding effective antibiotic selection for OME.

Related Concept Videos